Cargando…

Prevalence and determinants of anxiety and depression in long-term breast cancer survivors

BACKGROUND: There is a significant number of long-term breast cancer survivors in Germany. However, research on the psychological challenges of cancer survivors is limited. This analysis describes prevalence, development and determinants of depression and anxiety 5 to 6 years after diagnosis and ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Breidenbach, Clara, Heidkamp, Paula, Hiltrop, Kati, Pfaff, Holger, Enders, Anna, Ernstmann, Nicole, Kowalski, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827186/
https://www.ncbi.nlm.nih.gov/pubmed/35139815
http://dx.doi.org/10.1186/s12888-022-03735-3
_version_ 1784647575836557312
author Breidenbach, Clara
Heidkamp, Paula
Hiltrop, Kati
Pfaff, Holger
Enders, Anna
Ernstmann, Nicole
Kowalski, Christoph
author_facet Breidenbach, Clara
Heidkamp, Paula
Hiltrop, Kati
Pfaff, Holger
Enders, Anna
Ernstmann, Nicole
Kowalski, Christoph
author_sort Breidenbach, Clara
collection PubMed
description BACKGROUND: There is a significant number of long-term breast cancer survivors in Germany. However, research on the psychological challenges of cancer survivors is limited. This analysis describes prevalence, development and determinants of depression and anxiety 5 to 6 years after diagnosis and identifies predictors for an increase of anxiety and depression over time. METHODS: Data from 164 women was collected by survey and tumour documentation during post-operative hospital stay, 40 weeks and 5 to 6 years after diagnosis. Anxiety and depression were measured by the Hospital Anxiety and Depression Scale. Sankey-diagrams were created for visual presentation of prevalence over time. Logistic and linear regression models were calculated to identify determinants of anxiety and depression. RESULTS: Respondents had higher levels of depression and anxiety 5 to 6 years than 40 weeks after the diagnosis. Lower vocational status and having children were associated with depression, surgery type was correlated with anxiety, and age, as well as comorbidities, were predictors for both anxiety and depression 5 to 6 years after diagnosis. An increase of depression over time was more likely when having children and comorbidities. An increase in anxiety was less likely after cancer recurrence. CONCLUSIONS: Findings highlight that anxiety and depression are relevant burdens for breast cancer survivors in Germany. Several sociodemographic and clinical predictors are identified. There is need for psychosocial support after acute treatment and in the long-term. Research on psychological burdens of long-term breast cancer survivors in the identified vulnerable groups is needed.
format Online
Article
Text
id pubmed-8827186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88271862022-02-10 Prevalence and determinants of anxiety and depression in long-term breast cancer survivors Breidenbach, Clara Heidkamp, Paula Hiltrop, Kati Pfaff, Holger Enders, Anna Ernstmann, Nicole Kowalski, Christoph BMC Psychiatry Research Article BACKGROUND: There is a significant number of long-term breast cancer survivors in Germany. However, research on the psychological challenges of cancer survivors is limited. This analysis describes prevalence, development and determinants of depression and anxiety 5 to 6 years after diagnosis and identifies predictors for an increase of anxiety and depression over time. METHODS: Data from 164 women was collected by survey and tumour documentation during post-operative hospital stay, 40 weeks and 5 to 6 years after diagnosis. Anxiety and depression were measured by the Hospital Anxiety and Depression Scale. Sankey-diagrams were created for visual presentation of prevalence over time. Logistic and linear regression models were calculated to identify determinants of anxiety and depression. RESULTS: Respondents had higher levels of depression and anxiety 5 to 6 years than 40 weeks after the diagnosis. Lower vocational status and having children were associated with depression, surgery type was correlated with anxiety, and age, as well as comorbidities, were predictors for both anxiety and depression 5 to 6 years after diagnosis. An increase of depression over time was more likely when having children and comorbidities. An increase in anxiety was less likely after cancer recurrence. CONCLUSIONS: Findings highlight that anxiety and depression are relevant burdens for breast cancer survivors in Germany. Several sociodemographic and clinical predictors are identified. There is need for psychosocial support after acute treatment and in the long-term. Research on psychological burdens of long-term breast cancer survivors in the identified vulnerable groups is needed. BioMed Central 2022-02-09 /pmc/articles/PMC8827186/ /pubmed/35139815 http://dx.doi.org/10.1186/s12888-022-03735-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Breidenbach, Clara
Heidkamp, Paula
Hiltrop, Kati
Pfaff, Holger
Enders, Anna
Ernstmann, Nicole
Kowalski, Christoph
Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
title Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
title_full Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
title_fullStr Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
title_full_unstemmed Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
title_short Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
title_sort prevalence and determinants of anxiety and depression in long-term breast cancer survivors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827186/
https://www.ncbi.nlm.nih.gov/pubmed/35139815
http://dx.doi.org/10.1186/s12888-022-03735-3
work_keys_str_mv AT breidenbachclara prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors
AT heidkamppaula prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors
AT hiltropkati prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors
AT pfaffholger prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors
AT endersanna prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors
AT ernstmannnicole prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors
AT kowalskichristoph prevalenceanddeterminantsofanxietyanddepressioninlongtermbreastcancersurvivors